|
Si vous rencontrez un problème d'affichage cliquez ici.
|
|
|
Cher collègue,
|
Voici les dernières actualités de NetworkXPERT Gastro, votre service d'information sur les MICI.
Publications du Mercredi 20 décembre 2017
|
|
 |
| ACTUALITÉS CLINIQUES: |
| Inflammatory Bowel Disease Adversely Impacts Colorectal Cancer Surgery Short-term Outcomes and Health-Care Resource Utilization |
| Clinical and Translational Gastroenterology 2017; 8(11): e127 |
Inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (CRC).1, 2 Patients with IBD are 60% more likely to develop CRC than patients without IBD, which has been stable...
|
|
Version HTML |
Version PDF
|
Imprimer l'abstract
|
Partager cet article
|
| Patients’ perspective on bowel resection for inflammatory bowel disease |
| International Journal of Colorectal Disease 2018; 33(2): 219-22 |
With the growing number of medical therapies and improvement in surgical techniques and outcomes, coupled with disease heterogeneity, there is no single treatment algorithm that can be applied to all patients...
|
|
Version HTML |
Version PDF
|
Imprimer l'abstract
|
Partager cet article
|
| The experience of stigma in inflammatory bowel disease: An interpretive (hermeneutic) phenomenological study |
| Journal of Advanced Nursing 2018; 74(4): 838-51 |
Stigma is a complex and variable experience endured in a wider range of public, social and private relationships.
Kinship stigma enacted by family members may be particularly detrimental.
Emotional control,...
|
|
Version HTML |
Version PDF
|
Imprimer l'abstract
|
Partager cet article
|
| Systematic review and network meta‐analysis: first‐ and second‐line pharmacotherapy for moderate‐severe ulcerative colitis |
| Alimentary Pharmacology & Therapeutics 2018; 47(2): 162-75 |
Ulcerative colitis affects one in 200‐400 people in Western nations, and its global incidence and prevalence is rising.1 While the majority of patients have a mild‐moderate course, about...
|
|
Version HTML |
Version PDF
|
Imprimer l'abstract
|
Partager cet article
|
| Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease |
| Gut 2018; 67(1): 108-19 |
The gut microbiota plays a key role in the pathogenesis of IBD.
Known and presumed epidemiological risk factors for developing IBD such as mode of birth, breast feeding, smoking, hygiene, infections, antibiotics,...
|
|
Version HTML |
Version PDF
|
Imprimer l'abstract
|
Partager cet article
|
|
|
|
|
| Cette base de données bibliographiques est diffusée par LesEssentielsActu en toute indépendance éditoriale, avec le soutien institutionnel des laboratoires lesessentielsactu.com. Les informations diffusées dans le cadre de ce service peuvent éventuellement discuter ou suggérer certaines thérapeutiques qui ne sont pas validées par l'AMM. |
|
Informer un confrère | Modifier votre profil | Recevoir au format TXT | Se désabonner | Sources et critères
|
|
